Sabra Health Care REIT Inc
General ticker "SBRA" information:
- Sector: Real Estate
- Industry: Health Care REITs
- Capitalization: $4.2B
Sabra Health Care REIT Inc follows the US Stock Market performance with the rate: 55.3%.
Estimated limits based on current volatility of 1.7%: low 16.76$, high 17.32$
Factors to consider:
- Company pays dividends: last record date 2024-11-15, amount 0.30$ (Y7.08%)
- Current price 14.4% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [10.73$, 14.83$]
- 2024-12-30 to 2025-12-30 estimated range: [11.03$, 15.13$]
Financial Metrics affecting the SBRA estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.35
- Positive: Industry earnings per price (median), % of 6.86 > 5.96
- Positive: Operating profit margin, % of 33.33 > 19.51
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 0.25
- Positive: 7.18 < Operating cash flow per share per price, % of 9.06
Short-term SBRA quotes
Long-term SBRA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $525.65MM | $597.77MM | $647.51MM |
| Operating Expenses | $792.65MM | $1,016.63MM | $426.00MM |
| Operating Income | $-267.00MM | $-418.86MM | $221.52MM |
| Non-Operating Income | $347.67MM | $440.53MM | $-202.86MM |
| Interest Expense | $98.63MM | $105.47MM | $112.96MM |
| R&D Expense | $0.00MM | $0.00MM | $0.00MM |
| Income(Loss) | $80.67MM | $21.67MM | $18.66MM |
| Taxes | $1.84MM | $1.24MM | $2.00MM |
| Other Income(Loss) | $-192.08MM | $-98.03MM | $-2.90MM |
| Profit(Loss) | $-113.26MM | $-77.61MM | $13.76MM |
| Stockholders Equity | $3,379.53MM | $3,056.39MM | $2,802.53MM |
| Inventory | $119.78MM | $411.40MM | $0.00MM |
| Assets | $5,966.71MM | $5,747.67MM | $5,386.15MM |
| Operating Cash Flow | $356.39MM | $315.73MM | $300.57MM |
| Capital expenditure | $33.61MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-336.20MM | $-216.25MM | $103.13MM |
| Financing Cash Flow | $30.14MM | $-161.71MM | $-410.30MM |
| Earnings Per Share* | $-0.52 | $-0.34 | $0.06 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.